We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An international trial evaluating Elixir Medical’s DynamX Bioadaptor drug-eluting coronary artery implant has completed enrollment of 444 patients across 35 centers in Japan, Europe and New Zealand, the company said. Read More
Clearwater, Fla.-based Apyx Medical’s Renuvion dermal handpiece with the company’s helium plasma technology for dermal resurfacing succeeded in treating wrinkles in a clinical trial, researchers reported in the journal Lasers in Surgery and Medicine. Read More
The firm has a distribution agreement with Micro-Tech Endoscopy USA, which will begin phased distribution of the system to U.S. hospitals and surgery centers. Read More
Clinical use of the bioactive glass is supported by a 30-year history of research and more than 200 peer-reviewed publications, the company said. Read More
The company plans to roll out the mobile bolus feature throughout the spring in a series of limited launches, followed by an expanded launch later this summer. Read More
UK-based Parasym’s neuromodulation device significantly improved cardiac mechanics and inflammation in heart failure patients in a clinical trial at the University of Oklahoma. Read More
Patients with nonsurgical refractory back pain (NSRBP) treated with Nevro’s Senza high-frequency 10-kHz spinal cord stimulation (SCS) device saw a significant improvement in a clinical trial. Read More
Devices and replacement parts that are “printed” using new three-dimensional printing technologies must meet the same quality benchmarks as traditionally manufactured devices, trade groups emphasized in written comments to the FDA. Read More
Therma Bright said it is “the first company in the COVID-19 diagnostic testing space to successfully complete a 15-minute rapid antigen saliva-based U.S. study.” Read More
NPseal delivers the same type of negative pressure wound therapy as the currently available, more expensive and complex devices, the company said. Read More